OTC : AURX

Nuo Therapeutics, Inc. — Earnings Estimates

$1 USD

$0 (0.0%)

Volume
3K
Average Volume
3K
Market Capitalization
$48.41M
P/E Ratio
-20.00
Dividend Yield
0.00%
Price Target
$3.00
Year High
$3.23
Year Low
$0.84
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$1.11

Annual earnings financials

AURX financial data with annual/quarterly toggle

AURX GAAP EPS - Annual & Quarterly

AURX Sales Revenue - Annual & Quarterly

AURX Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

AURX Estimated and Actual Revenue by Quarter
AURX Estimated and Actual EPS by Quarter
AURX Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-12-31 1 -976.37K -976.37K -976.37K -993.42K -993.42K -993.42K
2026-09-30 1 -813.64K -813.64K -813.64K -827.85K -827.85K -827.85K
2026-06-30 1 -705.16K -705.16K -705.16K -717.47K -717.47K -717.47K
2026-03-31 1 -596.67K -596.67K -596.67K -607.09K -607.09K -607.09K
2025-12-31 1 -466.49K -466.49K -466.49K -474.64K -474.64K -474.64K
AURX Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-12-31 1 -482.85K -482.85K -482.85K 14.91M 14.91M 14.91M
2026-09-30 1 -482.85K -482.85K -482.85K 12.43M 12.43M 12.43M
2026-06-30 1 -482.85K -482.85K -482.85K 10.77M 10.77M 10.77M
2026-03-31 1 -482.85K -482.85K -482.85K 9.11M 9.11M 9.11M
2025-12-31 1 -482.85K -482.85K -482.85K 7.12M 7.12M 7.12M
AURX Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-12-31 1 1.8M 1.8M 1.8M 1 -0.01 -0.01 -0.01
2026-09-30 1 1.5M 1.5M 1.5M 1 -0.01 -0.01 -0.01
2026-06-30 1 1.3M 1.3M 1.3M 1 -0.01 -0.01 -0.01
2026-03-31 1 1.1M 1.1M 1.1M 1 -0.01 -0.01 -0.01
2025-12-31 1 860K 860K 860K 1 -0.01 -0.01 -0.01